TMCI - Treace Medical Concepts, Inc. Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

TMCI

TREACE MEDICAL CONCEPTS, INC.

NASDAQ

$4.81

▼ DOWN 1.43% (-0.07)

KEY STATISTICS

Market Cap$311.39 M

52w High$7.63

52w Low$1.17

Dividend Yield—

Frequency—

P/E-5.12

Volume231.83K

Shares Out.64.87M

COMPANY

LEADERSHIP

John T. Treace

CHIEF EXECUTIVE

John T. Treace

COMPENSATION 2026

Salary$755,353

Stock Awards$4,635,000

Incentive Plan Pay$0

All Other Comp.$14,837

Total$5,405,190

ABOUT

SECTOR

Healthcare

WENT PUBLIC

April 23, 2021

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

450

PRICE TARGET

Target High$16.00

Target Low$3.00

Target Median$6.50

Target Consensus$8.60

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$47.71M

NOV

5

THU

PRICE

$4.81 ▼ DOWN 1.43% (−$0.07)

About Treace Medical Concepts, Inc.

https://www.treace.com ↗

Treace Medical Concepts, Inc. designs and markets innovative orthopedic devices for foot and ankle surgeons, including the Lapiplasty bunion correction system, to improve surgical outcomes in the U.S.

INDUSTRY

Medical - Devices

A PRODUCT TREACE MEDICAL CONCEPTS, INC. IS KNOWN FOR

Lapiplasty® Lightning™ System

Lapiplasty® Lightning™ System

Treace Medical's Lightning™ System, an advanced addition to the Lapiplasty® platform, streamlines 3D bunion correction with new instrumentation, marking its upcoming limited market release in mid-2026.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

36

LISTED HERE

6

RANKED BY POSITION SIZE

0.00% · 227.8K

0.05% · 167.8K

0.00% · 101.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED

56.89%

HOLDERS

171

TOP 12 OF 171 · RANKED BY POSITION SIZE

Armistice Capital, LLC

6.4M sh · $8.53M

Gagnon Securities LLC

5.2M sh · $6.97M

4.1M sh · $27.06M

Blackrock, Inc.

3.7M sh · $24.71M

William Blair Investment Management, LLC

3.6M sh · $24.39M

Bank Of America Corp /De/

3.2M sh · $4.31M

Vanguard Group Inc

2.7M sh · $18.33M

Millennium Management LLC

1.7M sh · $11.48M

Cibc Private Wealth Group, LLC

1.7M sh · $9.92M

Jpmorgan Chase & Co

1.6M sh · $10.83M

Gagnon Advisors, LLC

1.5M sh · $3.76M

First Eagle Investment Management, LLC

1.5M sh · $3.58M

RATINGS SNAPSHOT

Overall rating: D+

Discounted Cash Flow1

Return On Equity1

Return On Assets1

Debt To Equity1

Price To Earnings1

Price To Book2

Overall Score1

INSIDER TRADES

★

DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER

Treace John T.

Purchase · 11.0K shares

2026-08-24

★

DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER

Treace John T.

Purchase · 5.0K shares

2026-08-21

★

DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER

Treace John T.

Purchase · 39.9K shares

2026-08-20

★

OFFICER: CHIEF LEGL & COMP OFF, CORPSEC

Elder Scot Michael

Sale · 16.3K shares

2026-08-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY

HOLD 2

NEUTRAL 2

BUY 1

UNDERWEIGHT 1

6 GRADES IN THE LAST 12 MONTHS

Truist Securities HOLD

Lake Street BUY

JP Morgan UNDERWEIGHT

SECTORS PEERS

PEER	PRICE
BVS	$14.25	COMPARE
CBLL	$24.59	COMPARE
EOLS	$9.17	COMPARE
KIDS	$22.38	COMPARE
RXST	$6.37	COMPARE
LAB	$0.67	COMPARE